logo
  

CleanSpark Appoints Scott Garrison As COO And Taylor Monnig As CTO

Bitcoin Miner CleanSpark, Inc. (CLSK) announced Wednesday the appointments of Scott Garrison as chief operating officer and Taylor Monnig as chief technology officer. They are both promoted to new C-suite positions.

Garrison, previously SVP of growth, and Monnig, previously SVP of mining technology, have been critical in CleanSpark's remarkable growth. Garrison has led business development and construction of the Company's data centers, while Monnig has been instrumental in developing the programs and leading the teams behind the Company's industry-leading uptime and miner performance.

Before joining CleanSpark in October 2020, Garrison spent the prior three decades of his professional experience leading cross-functional teams. He founded Linq360 and The Integration Center in Las Vegas. During that time, he partnered and consulted with renowned companies including HP, Verizon, Microsoft, and Samsung.

Monnig has developed and led CleanSpark's mining operations teams and the technology that supports them. He's also led successful efforts to improve fleet efficiency through software and hardware upgrades.

Prior to CleanSpark, Monnig co-founded TMGCore and served as the chief operating officer. In that role, he worked to develop and commercialize single phase and two-phase cooling technologies for high performance computing and bitcoin mining.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google announced its plan to invest $2 billion in Malaysia for cloud computing services and data centers with a view to meeting the soaring demand for AI and cloud services. It is expected that these investments and programs would contribute more than $3.2 billion to Malaysia's GDP and support 26,500 jobs by 2030. While reporting financial results for the first quarter on Thursday, electronics retailer Best Buy Co., Inc. (BBY) reiterated its adjusted earnings, revenue and comparable sales guidance for the full-year 2025. Comparable sales for the first quarter declined 6.1 percent. For fiscal 2025, the company... The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

Minutes of the latest Fed policy session dominated the economics scene this week. Find out what made policymakers give a “higher for longer” signal on interest rates. In Europe, the main news out this week was the inflation print from the U.K. Learn how the data was bad news for those hoping for an imminent rate cut from the Bank of England. Also, explore why New Zealand's central bank also hinted at a delay in its plans for interest rate reduction in future.

View More Videos
RELATED NEWS
Follow RTT